Elevance Health, Inc. (ELV)

Elevance Health Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Investments in Equity & Preferred Securities	6,329	-	-	-	-	-
Other Investments	29,040	37,181	35,954	35,950	32,590	33,373
Total Investments	36,628	37,181	35,954	35,950	32,590	33,373
Cash & Equivalents	10,232	9,491	8,288	6,526	7,387	4,880
Other Receivables	23,616	22,411	19,472	18,408	16,484	13,613
Property, Plant & Equipment	4,645	5,131	5,219	4,943	4,920	4,547
Goodwill	28,339	28,344	28,277	25,317	24,383	24,228
Other Intangible Assets	10,983	11,200	12,094	10,273	10,315	10,615
Other Current Assets	6,054	4,757	4,977	5,252	4,841	4,481
Long-Term Deferred Tax Assets	-	298	206	228	137	103
Other Long-Term Assets	5,941	2,681	2,402	2,031	1,698	1,620
Total Assets	126,438	121,494	116,889	108,928	102,755	97,460

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	6,632	7,322	6,927	6,910	5,607	4,970
Accrued Expenses	-	-	-	7	6	6
Insurance & Annuity Liabilities	3,463	3,777	4,394	6,378	6,736	6,323
Unpaid Claims	18,463	17,084	15,746	16,111	15,596	13,518
Unearned Premiums	1,640	1,493	1,508	1,402	1,112	1,153
Current Portion of Long-Term Debt	375	1,099	1,649	1,649	1,500	1,599
Current Portion of Leases	-	131	153	164	181	133
Short-Term Debt	-	150	365	225	265	275
Current Income Taxes Payable	276	151	75	-	-	-
Long-Term Debt	30,669	30,841	29,368	23,246	22,349	21,157
Long-Term Leases	-	529	658	685	751	864
Long-Term Deferred Tax Liabilities	2,206	2,110	2,148	1,970	2,015	2,805
Other Current Liabilities	13,405	9,973	9,954	9,723	9,496	7,710
Other Long-Term Liabilities	4,287	2,808	2,518	1,015	773	767
Total Liabilities	81,416	77,468	75,463	69,523	66,425	61,332

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2	2	2	2	2	2
Additional Paid-In Capital	8,917	8,938	8,911	8,868	9,084	9,148
Retained Earnings	36,675	35,393	33,549	31,749	29,647	27,088
Comprehensive Income & Other	-711	-451	-1,147	-1,313	-2,490	-178
Total Common Equity	44,883	43,882	41,315	39,306	36,243	36,060
Minority Interest	139	144	111	99	87	68
Shareholders' Equity	45,022	44,026	41,426	39,405	36,330	36,128
Total Liabilities & Equity	126,438	121,494	116,889	108,928	102,755	97,460

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Filing Date Shares Outstanding	216.87	220.7	227.35	232.67	237.46	241.3
Total Common Shares Outstanding	216.84	220.72	227.48	233.07	237.96	241.77
Total Debt	31,044	32,750	32,193	25,969	25,046	24,028
Net Cash (Debt)	-20,812	-23,259	-23,905	-19,443	-17,659	-19,148
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-94.21	-103.56	-102.64	-81.90	-72.73	-77.59
Book Value Per Share	206.99	198.81	181.62	168.64	152.31	149.15
Tangible Book Value	5,561	4,338	944	3,716	1,545	1,217
Tangible Book Value Per Share	25.65	19.65	4.15	15.94	6.49	5.03
Land	-	1	1	1	1	17
Buildings	-	15	27	37	38	172
Machinery	-	986	940	955	828	1,314
Leasehold Improvements	-	665	744	715	648	641

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Apr 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error